Clinical Trials Directory

Trials / Unknown

UnknownNCT00926549

Ocular Imaging With Spectral Domain Optical Coherence Tomography

Posterior and Anterior Ocular Imaging With Spectral Domain Optical Coherence Tomography

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
16 Years – 85 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to analyze macular retinal thickness and macular volume using the spectral domain - optical coherence tomography (SD-OCT) in normal eyes and in eyes with various ocular diseases.

Detailed description

Assessment of macular thickness is important for the treatment and follow-up of a variety of ocular diseases. The introduction of optical coherence tomography (OCT) has enabled clinicians to reliably detect small changes in macular thickness and to quantitatively evaluate the efficacy of different therapeutic modalities. In this study using the spectral domain-OCT, we examined the variations of macular retinal thickness and macular volume in normal eyes and in eyes with various ocular diseases.

Conditions

Interventions

TypeNameDescription
DEVICESpectral domain-OCT (Cirrus™ HD-OCT, Carl Zeiss Meditec AG)macular cube scanning

Timeline

Start date
2009-05-01
Primary completion
2009-09-01
Completion
2009-09-01
First posted
2009-06-23
Last updated
2009-06-23

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT00926549. Inclusion in this directory is not an endorsement.